1Dolan P. Modeling valuations for EuroQol health states[J]. Med Care, 1997, 35(11 ) : 1095-1108.
2Szende A, Oppe M, Devlin N. EQ-5D value sets:inventory ,comparative review and user guide[M]. Dordrecht : Springer,2007:57-102.
3Chen J,Wong CK,McGhee SM,et al. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD) [J]. PLoS 0ne,2014,9( 11 ) :el 12389.
4Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups :a multi- country study[J]. Qual Life Res, 2013 (22) : 1717-1727.
5Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population value set : the case of Japan[J]. Health Econ, 2002, 11(4):341-353.
6Cunillera O, Tresserras R, Rajmil L, et al. Discriminative capacity of the EQ-5D,SF-6D,and SF-12 as measures of health status in population health survey[J]. Qual Life Res,2010,19(6) :853-864.
